home / lobbying / lobbying_activities

lobbying_activities: 2220187

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2220187 633e93dc-c800-414b-b24e-f77f765e938e Q4 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2018 fourth_quarter CSP HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. S 2553 Know the Lowest Price Act of 2018 -- prohibits health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals S 2554 Patient Right to Know Drug Prices Act -- ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees S 2645 To establish a demonstration program under which the Drug Enforcement Administration provides grants to certain States to enable those States to increase participation in drug take-back programs. HR 6733 This Act may be cited as the Know the Cost Act of 2018. To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. HOUSE OF REPRESENTATIVES,SENATE   34000 0 0 2019-01-09T14:41:51.240000-05:00
Powered by Datasette · Queries took 0.442ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API